Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

HHS - 179 - Healthcare Infection Control Practices Advisory Committee - Authorized by Law


Committee NameHealthcare Infection Control Practices Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number179
Original Establishment Date1/19/1991Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*45
Current Charter Date1/19/2019Designated Fed Officer Position Title*Deputy Director, DHQP
Date Of Renewal Charter1/19/2021Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Michael
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Bell
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixM.D.
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*404-639-6490
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*(404) 639-3039
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*Scientific Technical Program Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Committee accomplishes its purpose by: 1) informing the development of CDC evidence-based guidelines for the prevention of healthcare-associated infections; 2) providing infection prevention and control guidance to address new or changing infectious disease threats such as pandemic influenza or antimicrobial (antibiotic) resistant pathogens; and 3) providing input into national surveillance efforts. During fiscal year 2020, the committee continued to provide input into the draft CDC guidelines: the Guideline for Infection Control in Healthcare Personnel, and the Guideline for Infection Prevention in Neonatal Intensive Care Unit Patients. The committee also provided input on antimicrobial use and resistance measures and antimicrobial stewardship efforts as well as core strategies of environmental cleaning and disinfection in hospitals. The committee also formed three new workgroups: bloodstream infection guideline update workgroup, long-term care and post-acute care workgroup, and the National Healthcare Safety Network workgroup.
How is membership balanced?*The committee consists of 14 public members. In addition to considerations of balanced racial and ethnic groups, gender, and geographic representation, to be effective the committee must also be balanced by depth of experience (e.g., newer to the field vs. senior-level) and perspective (e.g., national, state, local). Furthermore, the committee must maintain a balance of expertise that is dependent upon the planned work of the committee. The committee’s membership represents expertise from the fields of infectious diseases, healthcare-associated infection prevention, healthcare epidemiology, surgery, public health, nursing, and related fields.
How frequent & relevant are cmte mtgs?*In fiscal year 2020 the committee met in person once and twice via teleconference. Continued operation of the committee in fiscal year 2020 and beyond is required for the ongoing development, dissemination, and evaluation of CDC's infection control guidelines to prevent healthcare-associated infections and related adverse events, prevent the emergence of antimicrobial-resistant microorganisms, and improve quality of care across the spectrum of healthcare delivery, including long-term care. The committee provides critical guidance to CDC regarding these issues and as needed provides input on related issues such as surveillance and healthcare infection control practices for novel and emerging infectious diseases (e.g. Avian influenza, MERS, SARS, H1N1, SARS-CoV-2).
Why advice can't be obtained elsewhere?*CDC plays a unique role in healthcare-associated infection prevention activities in the U.S. and worldwide by developing and disseminating evidence-based infection control guidelines for preventing healthcare-associated infections and other adverse events in healthcare settings that are used to guide healthcare facilities in developing local protocols and procedures for infection control. Some recommendations become the standard for infection control when incorporated into other Agency and organizations standards (e.g., facility inspectors/surveyors such as those by Accreditation organizations or CMS). CDC actively investigates with State Health Departments and derives new evidence from outbreaks of healthcare-associated infections and CDC collaborates with other federal agencies and academic partners to apply those findings to update and improve prevention guidelines. CDC also manages and leads the National Healthcare Safety Network (NHSN), the nation’s most widely used healthcare-associated infection (HAI) tracking system. NHSN provides facilities, states, regions, and the nation with data from over 25,000 medical facilities to identify problem areas, measure progress of prevention efforts, and ultimately eliminate healthcare-associated infections. CDC uses input and advice from recognized experts described above to optimize guidelines and recommendations, assess trends, inform ongoing improvements to HAI monitoring and tracking, and review policy implications relevant to prevention of healthcare-associated infections.
Why close or partially close meetings?N/A
Recommendation RemarksJan Patterson, Vineet Chopra, and Kristina Bryant were extended through 12/31/2020.
Benjamin Schwartz is the new liaison representative for he National Association of County and City Officials and replaces Dan Nguyen.
Keith Kaye is the new liaison representative for the Society for Healthcare Epidemiology of America and replaces Louise Dembry.
Ashley Fell is the new liaison representative for the Council of State and Territorial Epidemiologists and replaces Marion Kainer.
Tara Palmore is the ex officio member for the National Institutes of Health and replaces David Henderson, who has retired.
Daniel Schwartz retired from federal service and is no longer the ex officio member for the Centers for Medicare and Medicaid Services. A replacement ex officio member is pending approval.
Eve Cuny and Hana Hinkle represent new liaison organizations to the committee.
This committee does not produce reports.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentHealthcare associated infections cost the United States tens of millions of dollars annually. Implementation and adherence to CDC infection control guidelines that were informed from input from HICPAC potentially represent substantial cost savings for the nation and improved patient safety by reducing morbidity and mortality.Grants Review CommentThis committee does not engage in grant review.
Number Of Recommendations*512Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThere was an increase of 9 recommendations from FY2019 to FY2020 (all from the November 2019 meeting). These recommendations included updates to current CDC guidelines (e.g., Guideline for Infection Control in Healthcare Personnel healthcare) as well as new recommendations (e.g., Guideline for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients). The Committee voted to approve the recommendations at public meetings and presented them to Division of Healthcare Quality Promotion (DHQP) leadership for acceptance. These guidelines are subject to CDC clearance for official approval by the agency, which includes DHQP, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and CDC Office of the Director leadership. These recommendations are then added to the agency’s formal healthcare infection prevention and control guidelines that are published online for implementation by healthcare professionals and other partners (e.g., state, federal, professional associations, industry) through user-friendly bundles and implementation strategies. Due to the ongoing response to COVID-19 by agency subject matter experts and committee members, many of the workgroup's activities have been placed on hold. The committee hopes to resume these activities in early-2021.Access Agency WebsiteYes
% of Recs Fully Implemented*90.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentRecommendations to the agency have been implemented and are reflected in CDC guidelines and possible CDC Guideline recommendation updates.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*10.00%Access PublicationsYes
% of Recs Partially Implemented CommentSometimes recommendations from the Committee are one of several internal and external inputs that CDC might use to inform decisions (e.g., federal register public comment period, other federal agency review, etc). Also, some recommendations will not be implemented until CDC Guidelines are published. CDC is currently working to refine, finalize, and publish the surveillance methods and guidelines that are informed by Committee's input.Access OtherYes
Agency Feedback*YesAccess CommentPublic Meetings
Agency Feedback Comment*The agency provides feedback to the committee through updates at regularly scheduled meetings and email communication to notify the HICPAC when action has been taken based on their recommendations.Narrative Description*CDC's mission is to promote health and quality of life by preventing and controlling disease, injury, and disability. The agency accomplishes its mission by working with partners to monitor health, develop and advocate sound public health policies, and implement prevention strategies. The Healthcare Infection Control Practices Advisory Committee supports CDC's mission by providing input into CDC's guidelines and recommendations for prevention of healthcare-associated infections (HAIs) as well as monitoring and tracking HAIs to improve patient safety in U.S. healthcare facilities.
Hide Section - COSTS


Payments to Non-Federal Members*$11,750.00Est Payments to Non-Fed Members Next FY*$38,500.00
Payments to Federal Members*$13,100.00Est. Payments to Fed Members Next FY*$36,025.00
Payments to Federal Staff*$94,041.00Estimated Payments to Federal Staff*$99,068.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$13,229.00Est Travel Reimb Non-Fed Members nextFY*$33,935.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$81,086.00Est. Other Costs Next FY*$86,312.00
Total Costs$213,206.00Est. Total Next FY*$293,840.00
Federal Staff Support (FTE)*0.80Est. Fed Staff Support Next FY*0.85
Cost RemarksEst Cost RemarksDue tp COVID-19, 2020 meetings were converted to teleconferences. Therefore, 2021 projected costs were estimated using 2020 projected costs.
Hide Section - Interest Areas

Interest Areas

Basic Science
Food and Drugs
Medical Devices
Health Care
Medical Education
Medical Practitioners
Public Health
Occupational Safety and Health
Health and Health Research
Medicine and Dentistry


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-036415Healthcare Infection Control Practices Advisory Committee2019
 COM-034619Healthcare Infection Control Practices Advisory Committee2018
 COM-001889Healthcare Infection Control Practices Advisory Committee2017
 COM-002276Healthcare Infection Control Practices Advisory Committee2016
 COM-004088Healthcare Infection Control Practices Advisory Committee2015
 COM-004373Healthcare Infection Control Practices Advisory Committee2014
 COM-005835Healthcare Infection Control Practices Advisory Committee2013
 COM-006643Healthcare Infection Control Practices Advisory Committee2012
 COM-008077Healthcare Infection Control Practices Advisory Committee2011
 COM-009123Healthcare Infection Control Practices Advisory Committee2010
 COM-010241Healthcare Infection Control Practices Advisory Committee2009
 COM-010767Healthcare Infection Control Practices Advisory Committee2008
 COM-011917Healthcare Infection Control Practices Advisory Committee2007
 COM-012912Healthcare Infection Control Practices Advisory Committee2006
 COM-014070Healthcare Infection Control Practices Advisory Committee2005
 COM-014447Healthcare Infection Control Practices Advisory Committee2004
 COM-015837Healthcare Infection Control Practices Advisory Committee2003
 COM-016615Healthcare Infection Control Practices Advisory Committee2002
 COM-017603Healthcare Infection Control Practices Advisory Committee2001
 COM-018518Healthcare Infection Control Practices Advisory Committee2000
 COM-019604Healthcare Infection Control Practices Advisory Committee1999
 COM-020372Hospital Infection Control Practices Advisory Committee1998
 COM-021787Hospital Infection Control Practices Advisory Committee1997